KRAS and cancer: The limit of detection (LOD) for detecting KRAS mutation was differently reported depending on the sample types; 0.05% for G12D and 0.01% for G12C using cancer cell lines with TaqMan MGB probes; 0.2% using FFPE CRAC samples with KRAS multiplex kit [13,16].